reported that allelic loss of PTEN was found in 38% of primary melanoma and 58% of melanoma metastasis, whereas missense mutations occurred in 7% of metastatic melanomas but in none of the primary tumors studied.18 This evidence concerns the gene PTEN and metastatic melanoma.